Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 26 Melanoma 18 Neoplasm Metastasis 14 Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Recurrence 9 Ovarian Neoplasms 7 Skin Neoplasms 6 Head and Neck Neoplasms 5 Carcinoma, Squamous Cell 5 Carcinoma, Renal Cell 5 Carcinoma, Basal Cell 5 Triple Negative Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Prostatic Neoplasms 3 Multiple Myeloma 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Merkel Cell 3 Adenocarcinoma 3 Sarcoma 2 Pancreatic Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Glioma 2

Interventions

Temozolomide 29 Bevacizumab 14 Radiotherapy 12 Trastuzumab 10 Lomustine 9 Capecitabine 8 paclitaxel-Angiopep-2 conjugate 6 Nivolumab 6 pembrolizumab 5 dabrafenib 5 abemaciclib 5 Radiation 5 icotinib 4 Surgical Procedures, Operative 4 Paclitaxel 4 Lapatinib 4 Irinotecan 4 Flucytosine 4 Dianhydrogalactitol 4 Corticotropin-Releasing Hormone 4 Chlorotoxin 4 Carboplatin 4 vocimagene amiretrorepvec 3 verubulin 3 tucatinib 3 osimertinib 3 motexafin gadolinium 3 XL647 3 Spermine Synthase 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Brain Neoplasms × cemiplimab × Clear all

NCT05317858 2026-04-16

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡